Miro Sciences clears TGA manufacturing hurdle for Crohn's trial

2 statements from 2 sources on Nov 12, 2026, 01:24–01:28 UTC

News

Updated Nov 12, 2026 01:28 UTC

Statements (2)

Bullish
Miro Sciences cleared a key manufacturing hurdle for its Crohn's disease trial after the TGA inspected its partner's facility.
thewest.com.auNov 12, 2026 01:28 UTCHigh importance
Neutral
Miro Sciences cleared a TGA manufacturing hurdle for its Crohn's trial
smh.com.auNov 12, 2026 01:24 UTC

Finance Pulse API

This page is built from the Finance Pulse API: every statement, source and sentiment above. One request returns it as JSON:

GET https://finance-pulse.p.rapidapi.com/v2/topics/c16112ef-849c-4950-8e85-8a7eca80cba5